Well Being Journal, Issaquah WA., May 1994
The Well Being Journal (March/April 1994) reported that 37 of 49 top
officials of the FDA who left the agency moved into high corporate
positions with the companies they had regulated, and 150 FDA officials
owned stock in the companies they were suppose to represent. Recently the
Seattle Post Intelligencer (April 21,1994) disclosed that top FDA
officials who have shepherded the bovine somatotropin drug (rbGH, or dairy
cow growth hormone) through the FDA approval process were previously on
the payroll of Monsanto, the drug manufacturer. "Three top-level FDA
officials who helped develop the FDA’s formal opinion that the drug was
safe was paid by Monsanto for legal or scientific work on the drug before
they joined the FDA."
Rep. Geroge Brown Jr., (D-CA) and two other Congressman have asked
for a General Accounting Office investigation of the matter.
"The appearance of collision with a private company and conflict of
interest are too blatant to ignore."
Readers are encouraged to phone or write and request support for the
investigation from their representatives.
–
e-mail: deli…@eskimo.com
mosaic: http://eskinews.eskimo.com/~delisle/index.html